Dr. Erik Matthew Dunki-Jacobs, MD

Dr. Dunki-Jacobs practices at The Christ Hospital in Cincinnati, Ohio, part of The Christ Hospital Health Network.

Dr. Dunki-Jacobs' NPI, 1639461882, was assigned on May 6, 2011. Dr. Dunki-Jacobs graduated from University of Cincinnati College of Medicine in 2006. Dr. Dunki-Jacobs holds Ohio license 35.121395.

Dr. Dunki-Jacobs' primary practice is The Christ Hospital, at 2139 Auburn Avenue, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 585-2000.

Dr. Dunki-Jacobs' primary practice is The Christ Hospital in Cincinnati, Ohio, part of The Christ Hospital Health Network. Dr. Dunki-Jacobs is also affiliated with Bethesda North Hospital. The medical group on file is TriHealth. Dmand AI also links Dr. Dunki-Jacobs to 2 more hospitals, 3 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunki-Jacobs practices, 8 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Dunki-Jacobs' primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Dunki-Jacobs is licensed in Ohio.

CMS data shows 172 Medicare services from Dr. Dunki-Jacobs across 6 procedure codes in 2024, for 153 Medicare patients. Medicare paid $17,373 for them.

CMS counts 153 Medicare patients who saw Dr. Dunki-Jacobs in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dunki-Jacobs' median patient age at 70, with 45% women.

In 2024, Dr. Dunki-Jacobs wrote 67 Medicare Part D claims for 34 patients. 78% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $64 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Dunki-Jacobs for performance year 2024, reported through an alternative payment model (APM). Dr. Dunki-Jacobs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of melanoma (skin cancer) excision by Dr. Dunki-Jacobs, more than 85% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Dunki-Jacobs, published from 2011 to 2021. 2013 was the busiest year, with 2. The most frequent topics are Lymphatic Metastasis, Postoperative Complications and Melanoma. Dr. Dunki-Jacobs has published most often in Am Surg. Dr. Dunki-Jacobs' most frequent co-authors are Kelly M. McMasters, MD, Glenda Grace Callender, MD and Prejesh Philips, MD.

CMS Open Payments shows 35 general payments to Dr. Dunki-Jacobs from 19 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Histosonics, Inc. paid the most, $1,182.

Dr. Dunki-Jacobs graduated from University of Cincinnati College of Medicine in 2006.